World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
19543
World Ranking
17281
National Ranking
329

Overview

Marja-Liisa Dahl is affiliated with the Karolinska University Hospital in Sweden and has contributed extensively to medical research, particularly in endocrinology, pharmacology, and related fields. Their publication record includes studies focusing on hormonal and reproductive systems, doping in sports, and pharmacological treatments.

The scientist's research spans several main fields, with the majority of their work categorized under medicine. Key subfields include endocrinology, diabetes and metabolism, pharmacology, sociology and political science, pediatrics, perinatology and child health, and cell biology.

Research topics covered by Marja-Liisa Dahl include:

  • Hormonal and reproductive studies
  • Doping in sports
  • Pharmacology and obesity treatment
  • Muscle metabolism and nutrition
  • Schizophrenia research and treatment
  • Pharmaceutical practices and patient outcomes
  • Treatment of major depression

Among the recent papers featuring Marja-Liisa Dahl are:

  • Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents, 2020, Drug Testing and Analysis
  • Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants, 2021, The World Journal of Biological Psychiatry
  • Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet, 2020, Expert Review of Clinical Pharmacology
  • Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality, 2020, Medicina
  • Women's Experiences of Using Anabolic Androgenic Steroids, 2021, Frontiers in Sports and Active Living

Frequent co-authors collaborating with Marja-Liisa Dahl include Annica Börjesson, Lena Ekström, Mikael Lehtihet, Veronica Vicente, and Marine L. Andersson.

The venues where this scientist's work often appears include Scientific Reports, International Journal of Qualitative Studies on Health and Well-Being, British Journal of Clinical Pharmacology, Drug Testing and Analysis, and The World Journal of Biological Psychiatry.

Best Publications

  • A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

    Sarah C. Sim;Sarah C. Sim;Carl Risinger;Carl Risinger;Marja‐Liisa Dahl;Marja‐Liisa Dahl;Eleni Aklillu;Eleni Aklillu

  • Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

    Inger Johansson;Eva Lundqvist;Leif Bertilsson;Marja-Liisa Dahl

  • Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs

    Leif Bertilsson;Marja-Liisa Dahl;Per Dalén;Ayman Al-Shurbaji

  • CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.

    J Kirchheiner;K Brosen;Marja-Liisa Dahl;LF Gram

  • Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

    Maria Gabriella Scordo;Maria Gabriella Scordo;Maria Gabriella Scordo;Vittorio Pengo;Vittorio Pengo;Vittorio Pengo;Edoardo Spina;Edoardo Spina;Edoardo Spina;Marja Liisa Dahl;Marja Liisa Dahl;Marja Liisa Dahl

  • Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.

    M L Dahl;I Johansson;L Bertilsson;M Ingelman-Sundberg

  • 10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes.

    Per Dalén;Marja-Liisa Dahl;Maria Luisa Bernal Ruiz;Jan Nordin

  • Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

    L Bertilsson;JA Carrillo;ML Dahl;A Llerena

  • Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

    Kristina Melkersson;Marja-Liisa Dahl

  • Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population

    Ümit Yasar;Erik Eliasson;Marja-Liisa Dahl;Inger Johansson

  • Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia

    Klas R. Linderholm;Elisabeth Skogh;Sara K. Olsson;Marja-Liisa Dahl;Marja-Liisa Dahl

  • Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

    Arzu Gunes;Marja-Liisa Dahl

  • Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.

    L Bertilsson;M-L Dahl;F Sjöqvist;A Åberg-Wistedt

  • Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

    Maria Gabriella Scordo;Maria Gabriella Scordo;Eleni Aklillu;Umit Yasar;Marja-Liisa Dahl

  • Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype

    Ming Chang;Marja-Liisa Dahl;Gunnel Tybring;Eva Gotharson

  • Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19.

    M Chang;G Tybring;ML Dahl;E Gotharson

  • Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.

    Ümit Yasar;Ümit Yasar;Cecilia Forslund‐Bergengren;Cecilia Forslund‐Bergengren;Gunnel Tybring;Gunnel Tybring;Pedro Dorado;Pedro Dorado

  • Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.

    Marja‐Liisa Dahl;Inger Johansson;Margareta Porsmyr Palmertz;Magnus Ingelman‐Sundberg

  • Genetic polymorphism of cytochrome P4502E1 in a Swedish population : relationship to incidence of lung cancer

    Irene Persson;Inger Johansson;Helene Bergung;Marja-Liisa Dahl

  • Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.

    Maria Gabriella Scordo;Edoardo Spina;Gabriella Facciolà;Angela Avenoso

Frequent Co-Authors

Leif Bertilsson
Leif Bertilsson Karolinska University Hospital
Folke Sjöqvist
Folke Sjöqvist Karolinska Institute
Magnus Ingelman-Sundberg
Magnus Ingelman-Sundberg Karolinska Institute
Inger Johansson
Inger Johansson Karolinska Institute
Edoardo Spina
Edoardo Spina University of Messina
Anders Rane
Anders Rane Karolinska University Hospital
Olof Beck
Olof Beck Karolinska Institute
Michel Eichelbaum
Michel Eichelbaum University of Tübingen
Sophie Erhardt
Sophie Erhardt Karolinska Institute
Harry Scheinin
Harry Scheinin Turku University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open numerous doors for aspiring medical professionals or those seeking to advance in the field. Many students choose dnp programs without dissertation for a flexible and research-oriented doctorate, which can save time and allow a greater focus on clinical skills.

If you're looking to jumpstart your nursing career quickly, consider fast track medical programs. These accelerated pathways help you enter the workforce sooner, making them a practical choice for career changers or recent graduates.

Advanced practice roles are also accessible through the shortest online pmhnp programs. These allow working nurses to gain specialized mental health credentials at an accelerated pace, meeting the growing demand for mental health professionals.

For those interested in the administrative side of medicine, a bachelors in healthcare administration prepares students for leadership roles in hospitals, clinics, and other healthcare organizations—all attainable online with affordability in mind.

Best Scientists Citing Marja-Liisa Dahl

Trending Scientists